appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Sun Pharmaceutical Industries Ltd
SUNPHARMA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Dr Reddy's Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Abbott India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Sun Pharma vs Cipla vs Auro Pharma: How should you trade these healthcare stocks
10 hours ago•Business Today
Inverse H&S in pharma index could revive a positive bias for short-term
16 hours ago•Business Standard
India Pharma I U.S. Prescription, Volume Trends - A Few Surprises: Systematix
16 hours ago•Bloomberg Quint
Recent EventsAll events
Trading Window
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Updates
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Further to our intimation filed on 2nd March 2023, regarding an Information Technology ( IT ) security incident, we wish to provide an update.'. | Download
Cash Dividend
Interim • Div/Share: ₹ 7.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant